<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Evaluation of a neck mass in adults</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Evaluation of a neck mass in adults</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Evaluation of a neck mass in adults</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Daniel G Deschler, MD, FACS</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Joseph Zenga, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Marvin P Fried, MD, FACS</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Wenliang Chen, MD, PhD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jun 15, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>A new neck mass is a relatively common head and neck problem. There often are no associated symptoms other than the recognition of a new "lump" noted incidentally on palpation while grooming or noticed by another individual. The mass may be the only manifestation of a serious and potentially malignant pathology, especially in the adult population. </p><p>Evaluation of the neck mass must be approached in a thorough and disciplined manner. A thorough history and physical examination are essential first steps in the evaluation [<a href="#rid1">1,2</a>]. This will narrow the diagnostic possibilities and help determine the appropriate next diagnostic steps.</p><p>The diagnostic approach to evaluation of a neck mass in <strong>adults</strong> will be reviewed here. The differential diagnosis in a patient presenting with a neck mass is often extensive, which is discussed separately. (See  <a class="medical medical_review" href="/d/html/6857.html" rel="external">"Differential diagnosis of a neck mass"</a>.)</p><p>Specific disease entities in adults that may present as a neck mass are discussed in separate topics:</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/2155.html" rel="external">"Thyroglossal duct cyst, thyroglossal duct cyst cancer, and ectopic thyroid"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/5231.html" rel="external">"Paragangliomas: Epidemiology, clinical presentation, diagnosis, and histology"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/3393.html" rel="external">"Overview of the diagnosis and staging of head and neck cancer"</a>.)</p><p></p><p>The differential diagnosis of a neck mass also varies greatly with the age of the patient; evaluation of a neck mass in children is discussed separately:</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/6061.html" rel="external">"Cervical lymphadenitis in children: Diagnostic approach and initial management"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/5982.html" rel="external">"Cervical lymphadenitis in children: Etiology and clinical manifestations"</a>.)</p><p></p><p class="headingAnchor" id="H3866229125"><span class="h1">OUR APPROACH</span><span class="headingEndMark"> — </span>Our approach to evaluating a neck mass in adults relies upon findings on the initial history and physical examination to triage neck masses into three categories (possible infectious, possible malignant, and possible inflammatory) and directs further evaluation with laboratory tests, imaging studies, tissue biopsies, and referrals accordingly. Our approach is consistent with the 2017 clinical practice guidelines from the American Academy of Otolaryngology–Head and Neck Surgery [<a href="#rid3">3</a>]. </p><p class="headingAnchor" id="H2682308173"><span class="h2">Exclude or treat bacterial infection</span><span class="headingEndMark"> — </span>Infectious neck masses are uncommon but must be promptly treated or excluded.</p><p>Infectious etiologies of a neck mass are suspected based on a history of the mass developing within a few days or weeks of an upper respiratory infection, dental infection, trauma, travel, or exposure to certain animals, or based on one or more of the following physical findings [<a href="#rid3">3</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Warmth or erythema of the overlying skin</p><p class="bulletIndent1"><span class="glyph">●</span>Swelling or tenderness to palpation of the mass</p><p class="bulletIndent1"><span class="glyph">●</span>Fever, tachycardia, or other systemic signs of infection</p><p class="bulletIndent1"><span class="glyph">●</span>Rhinorrhea, odynophagia, otalgia, odontalgia, or other symptoms of a head and neck infection</p><p></p><p>Patients with a neck mass that appears to be infectious should be treated with a course of broad-spectrum antibiotics (eg, <a class="drug drug_general" data-topicid="8676" href="/d/drug information/8676.html" rel="external">amoxicillin-clavulanate</a>) and reevaluated in two weeks. If the mass has completely resolved, the patient should be reevaluated in another two to four weeks for recurrence [<a href="#rid4">4</a>]. </p><p>Patients who do not respond to or only partially respond to antibiotics, or who have recurrence after cessation of antibiotics, require further workup to exclude malignancy. </p><p>Most neck masses in adults are neoplastic rather than infectious. Patients who do not have signs or symptoms suggestive of an infectious etiology should not receive antibiotics but instead undergo further workup.</p><p class="headingAnchor" id="H327571389"><span class="h2">Exclude malignancy</span><span class="headingEndMark"> — </span>Malignancy is the greatest concern in adult patients with a neck mass. </p><p class="headingAnchor" id="H1152639842"><span class="h3">Identification</span><span class="headingEndMark"> — </span>A malignant neck mass should be suspected based on the following "stand-alone" features detected by the initial history and physical examination [<a href="#rid3">3</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>History:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Lack of an infectious etiology </p><p class="bulletIndent2"><span class="glyph">•</span>Duration of ≥2 weeks or unknown </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Physical examination:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Size &gt;1.5 cm</p><p class="bulletIndent2"><span class="glyph">•</span>Firm texture to palpation (see <a class="local">'Characteristics of the mass'</a> below)</p><p class="bulletIndent2"><span class="glyph">•</span>Fixed or reduced mobility</p><p class="bulletIndent2"><span class="glyph">•</span>Ulceration of overlying skin</p><p></p><p>Additional findings that may increase the suspicion for a malignant etiology include [<a href="#rid3">3</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>History:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Age &gt;40 years</p><p class="bulletIndent2"><span class="glyph">•</span>Tobacco or alcohol abuse</p><p class="bulletIndent2"><span class="glyph">•</span>History of head and neck cancer</p><p class="bulletIndent2"><span class="glyph">•</span>History of skin cancer of the scalp, face, or neck</p><p class="bulletIndent2"><span class="glyph">•</span>Immunocompromised status</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Symptoms:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Hoarseness or recent voice change</p><p class="bulletIndent2"><span class="glyph">•</span>Otalgia or recent hearing loss ipsilateral to the neck mass</p><p class="bulletIndent2"><span class="glyph">•</span>Nasal congestion or epistaxis ipsilateral to the neck mass</p><p class="bulletIndent2"><span class="glyph">•</span>Oral cavity or oropharyngeal ulcer</p><p class="bulletIndent2"><span class="glyph">•</span>Odynophagia or dysphagia</p><p class="bulletIndent2"><span class="glyph">•</span>Pharyngitis or "sore throat"</p><p class="bulletIndent2"><span class="glyph">•</span>Hemoptysis or blood in saliva</p><p class="bulletIndent2"><span class="glyph">•</span>Dyspnea</p><p class="bulletIndent2"><span class="glyph">•</span>Unexplained weight loss</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Physical findings:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Nontender neck mass</p><p class="bulletIndent2"><span class="glyph">•</span>Asymmetric tonsils</p><p class="bulletIndent2"><span class="glyph">•</span>Skin lesions on scalp, face, or neck</p><p></p><p>A study of 4103 patients referred to otolaryngology for neck mass identified a malignancy in 5 percent [<a href="#rid5">5</a>]. Increasing age (8.4 percent for those &gt;70 versus 2.1 percent for those &lt;40), male sex (adjusted odds ratio [aOR] 2.38 versus female), white non-Hispanic ethnicity (aOR 1.75 versus other races/ethnicities), increasing minimum mass dimension (31 percent for mass &gt;2 cm versus 3 percent for mass &lt;1 cm), multiple neck masses (aOR 5.07 versus single), or heterogeneous architecture/ill-defined borders (aOR 2.57 versus normal features on imaging) were associated with malignancy. </p><p class="headingAnchor" id="H930468053"><span class="h3">Evaluation</span><span class="headingEndMark"> — </span>Patients suspected of having a malignant neck mass based on the initial history and physical examination should:</p><p class="bulletIndent1"><span class="glyph">●</span>Be referred to a specialist (eg, otolaryngologist or ENT specialist) for a targeted head and neck examination in the office or under anesthesia.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Undergo a neck computed tomography (CT) or magnetic resonance imaging (MRI) evaluation with intravenous contrast. (See <a class="local">'Imaging studies'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Undergo biopsy of the neck mass (typically a fine-needle aspiration but may require core or open biopsy). (See <a class="local">'Diagnostic studies'</a> below.)</p><p></p><p>Patients diagnosed with a malignant neck mass are treated according to established protocols for the primary cancer. Patients whose malignancy workup is negative require further testing to elucidate an alternate (benign) etiology.</p><p class="headingAnchor" id="H3903619941"><span class="h2">Establish diagnosis</span><span class="headingEndMark"> — </span>Patients with a neck mass that is not infectious or at increased risk for malignancy require further testing to elucidate the etiology of the mass. These ancillary tests include laboratory tests (eg, for viral antibody titers) and a few selected imaging studies (eg, neck ultrasound for thyroid nodules or chest CT for tuberculosis or sarcoidosis) [<a href="#rid3">3</a>]. (See <a class="local">'Laboratory studies'</a> below and <a class="local">'Imaging studies'</a> below.)</p><p>Performance of such ancillary tests should be directed by clinical findings, rather than indiscriminate, in order to increase yield and reduce cost. When clinically indicated, ancillary tests can be performed at any time in any patient with a neck mass. As examples, they can be performed in patients with a suspected malignant neck mass simultaneously with the malignancy workup to avoid delaying a cancer diagnosis, or after a negative malignancy workup to pursue an alternate (benign) etiology.</p><p>After completion of ancillary tests, patients diagnosed with a specific condition should be treated accordingly. Those without a specific diagnosis should be followed clinically until the neck mass has resolved or a diagnosis can be established. </p><p class="headingAnchor" id="H2"><span class="h1">PATIENT HISTORY</span><span class="headingEndMark"> — </span>A thorough patient history will often narrow the differential diagnosis of a neck mass.</p><p class="headingAnchor" id="H3"><span class="h2">Age</span><span class="headingEndMark"> — </span>The age of the patient is a critical factor in the indicated diagnostic workup [<a href="#rid6">6-8</a>]: </p><p class="bulletIndent1"><span class="glyph">●</span>&lt;16 – The majority of pediatric neck masses are either of inflammatory or congenital origin.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>16 to 40 – Inflammatory or congenital etiologies also account for the majority of neck masses in the age group from 16 to 40, although the frequency of malignant causes starts to increase [<a href="#rid7">7,9</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>&gt;40 – A neck mass in an adult over the age of 40 should be considered neoplastic, and potentially malignant, until proven otherwise [<a href="#rid7">7,10</a>]. The probability of a malignant neck mass is further increased in the setting of tobacco or alcohol use. (See <a class="local">'Exclude malignancy'</a> above.)</p><p></p><p class="headingAnchor" id="H4"><span class="h2">Mass growth pattern</span><span class="headingEndMark"> — </span>Characteristics of the mass, such as its duration, growth pattern, and absence or presence of pain, are critical in making the diagnosis.</p><p class="bulletIndent1"><span class="glyph">●</span>Masses that are present for years with little change are likely benign neoplasms (eg, benign salivary gland tumors, peripheral nerve sheath tumors, or paragangliomas) [<a href="#rid11">11</a>]. However, human papillomavirus (HPV)-associated oropharyngeal squamous cell carcinoma (OPSCC) can present with a unilateral neck mass with little perceptible change for months or years. This entity can mimic benign masses and lead to diagnostic delay [<a href="#rid12">12</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Rapidly expanding masses raise concern for infectious processes or rapidly growing lymphomas or lymphovascular malformations [<a href="#rid13">13</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Masses that fluctuate over time and increase with viral illnesses or upper respiratory tract infections are often congenital cysts.</p><p></p><p class="headingAnchor" id="H5"><span class="h2">Symptoms</span><span class="headingEndMark"> — </span>Pain is often related to rate of growth and expansion but can be related to direct neural invasion in the setting of certain malignancies. As an example, a fixed parotid mass that presents with pain is highly likely to be malignant.</p><p>Symptoms of voice change, hoarseness, dysphagia, and otalgia may indicate cervical lymph node metastasis from an underlying upper aerodigestive tract malignancy. (See <a class="local">'Identification'</a> above.)</p><p class="headingAnchor" id="H6"><span class="h2">Other history</span><span class="headingEndMark"> — </span>A review of systems should include the presence of fever, night sweats, or weight loss. This constellation of symptoms is suspicious for lymphoma, whereas high, spiking fever suggests acute infection [<a href="#rid14">14</a>].</p><p>Important aspects of the social history include tobacco use (frequency, total amount, method of use), alcohol use, illicit drug use (specifically intravenous drug use), and HIV status. An occupational history, occupational exposures, animal exposures, and recent travel history should also be included.</p><p>Although smoking rates have decreased in the United States, with a consequent drop in the number of diagnosed oral cavity and laryngeal cancers, the incidence of HPV-associated OPSCC has markedly increased [<a href="#rid15">15,16</a>]. Patients with HPV-associated OPSCC have a distribution of demographic characteristics that is distinct from those with tobacco- or alcohol-related head and neck cancer. Patients with HPV-associated OPSCC are most commonly white men, nonsmokers, younger than 65 years, and have few comorbidities. They are typically of high socioeconomic status and have risk factors for HPV exposure several decades prior to presentation [<a href="#rid17">17-19</a>].</p><p>A large database analysis by the Centers for Disease Control (CDC) found that over 11,000 cases of OPSCC were diagnosed yearly in the United States between 2004 and 2008 [<a href="#rid20">20</a>]. This study was repeated for the years 2008 through 2012 and found that the incidence had increased to over 16,000 cases per year [<a href="#rid21">21</a>]. Furthermore, based on a CDC genotyping study, currently 70 percent of all OPSCCs are HPV associated [<a href="#rid22">22</a>]. Extrapolating from these data, the incidence of HPV-associated OPSCC increases each year by over 700 cases in the United States, with the yearly incidence in HPV-associated OPSCC likely to exceed 24,000 cases in 2024 [<a href="#rid23">23</a>]. </p><p>Most importantly, in over two-thirds of cases, this disease will present as an asymptomatic neck mass [<a href="#rid24">24</a>]. For this reason, there are often several barriers to timely and accurate diagnosis in these patients. In a study of 208 patients with HPV-associated OPSCC, an asymptomatic neck mass was the initial presentation in 69 percent. In almost 10 percent of patients, however, the time interval between first presentation and diagnosis was over one year. These diagnostic delays were due to either clinician- or patient-related factors. Clinician-related factors included delay in referral from primary care providers or misdiagnosis by otolaryngologists. Patient-related factors included delay in seeking care or noncompliance with diagnostic workup, which in large part is due to the asymptomatic nature of small or unknown primary tumors [<a href="#rid25">25</a>]. For these reasons, it is imperative that patients with an asymptomatic neck mass undergo timely and thorough diagnostic workup along with prompt specialist referral when indicated [<a href="#rid26">26</a>].</p><p>HPV-associated OPSCC is discussed in further detail in another topic. (See  <a class="medical medical_review" href="/d/html/3378.html" rel="external">"Epidemiology, staging, and clinical presentation of human papillomavirus associated head and neck cancer", section on 'Oropharyngeal carcinoma'</a>.)</p><p class="headingAnchor" id="H2750606414"><span class="h2">COVID-19 vaccination</span><span class="headingEndMark"> — </span>The immunogenicity of the COVID-19 vaccine can lead to reactive cervical, axillary, or subpectoral adenopathy ipsilateral to the injection site. Abnormal nodal findings after the COVID-19 vaccine have been identified in 5 to 10 percent of patients, usually within two weeks of vaccination [<a href="#rid27">27,28</a>]. Vaccine-related adenopathy often may be enlarged (&gt;1 cm) with fluorodeoxyglucose (FDG) avidity. While such nodes will often demonstrate preserved morphology [<a href="#rid29">29</a>], reactive inflammation may also lead to loss of the fatty hilum [<a href="#rid30">30</a>]. When biopsied, these nodes reveal reactive follicular hyperplasia.</p><p>For these reasons, elective screening studies for head and neck cancer patients should be scheduled either before or at least six weeks after the COVID-19 vaccine to allow reactive adenopathy to resolve [<a href="#rid31">31</a>]. When imaging must be obtained sooner, we recommend administering the vaccine contralateral to the patient's cancer when possible, with both doses given in the same arm. Most importantly, clear communication is essential between the patient, oncology team, and radiologist about the location and timing of the COVID-19 vaccine to ensure proper interpretation of imaging. </p><p>Management of post-vaccination abnormal lymphadenopathy requires careful consideration of the clinical context. In most cases, vaccination history and nodal morphology is sufficient to rule out metastatic adenopathy. If there is high concern for potential disease involvement that would alter management, however, repeat imaging may be obtained in two weeks to assess for return to normal morphology. Alternatively, lymph node sampling may be performed. (See <a class="local">'Diagnostic studies'</a> below.)</p><p class="headingAnchor" id="H7"><span class="h1">PHYSICAL EXAMINATION</span><span class="headingEndMark"> — </span>The physical examination should include a careful evaluation of all anatomical areas that may be relevant to the neck mass. Although the focus will initially be on the head and neck, a complete examination can indicate signs of systemic illness, including infections, inflammatory conditions, and malignancy.</p><p class="headingAnchor" id="H8"><span class="h2">Anatomy of the neck</span><span class="headingEndMark"> — </span>Familiarity with neck anatomy is critical for diagnosis and management of disease processes affecting this region. The location of the mass can focus the differential diagnosis [<a href="#rid2">2,9</a>]. (See  <a class="medical medical_review" href="/d/html/6857.html" rel="external">"Differential diagnosis of a neck mass"</a>.)</p><p>The neck is traditionally divided into the central and the lateral neck  (<a class="graphic graphic_figure graphicRef74489" href="/d/graphic/74489.html" rel="external">figure 1</a>).</p><p>Additionally, the localization of lymph nodes in the neck is shown in a figure  (<a class="graphic graphic_figure graphicRef69528" href="/d/graphic/69528.html" rel="external">figure 2</a>), and patterns of lymphatic drainage are shown in a table  (<a class="graphic graphic_table graphicRef77551" href="/d/graphic/77551.html" rel="external">table 1</a>).</p><p class="bulletIndent1"><span class="glyph">●</span>The central neck includes midline structures such as the hyoid bone, thyroid and cricoid cartilages, thyroid isthmus, and trachea.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The lateral neck is divided by the sternocleidomastoid muscle (SCM) into an anterior triangle that has its base at the undersurface of the mandible and its peak at the junction of the SCM and sternoclavicular joint. The remaining sides of the anterior triangle are the SCM and the medial abutment to the central neck structures. The anterior triangle can be further subdivided by the digastric muscle into the submental and submandibular triangles  (<a class="graphic graphic_figure graphicRef74489" href="/d/graphic/74489.html" rel="external">figure 1</a>).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The posterior triangle has its base at the clavicle and its peak at the mastoid tip. The anterior border of the posterior triangle is the SCM, and the posterior border is the trapezius muscle. The posterior belly of the omohyoid further subdivides the posterior triangle into the subclavian triangle located below this muscle and the occipital triangle above it  (<a class="graphic graphic_figure graphicRef74489" href="/d/graphic/74489.html" rel="external">figure 1</a>).</p><p></p><p class="headingAnchor" id="H9"><span class="h2">Mass localization</span><span class="headingEndMark"> — </span>Localization of the mass can suggest specific etiologies, as follows:</p><p class="bulletIndent1"><span class="glyph">●</span>Preauricular and angle of the jaw – Likely represents either salivary or lymphoid tissue in the parotid system. Therefore, it is essential to consider facial nerve function in evaluation and tissue sampling.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Central neck – Most commonly represents tissue that is thyroid or malignant in origin. This could also represent a dermoid cyst.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Anterior aspect of the SCM, usually the high jugulodigastric region – In adults, enlarged lymph nodes often occur in this location and suggest potential malignant involvement [<a href="#rid32">32,33</a>]. Congenital masses, such as the second branchial cleft cyst, are common in the pediatric population and are occasionally present in adults. (See  <a class="medical medical_review" href="/d/html/6857.html" rel="external">"Differential diagnosis of a neck mass", section on 'Branchial cleft cyst'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Posterior triangle – Masses in this location should elicit a high index of suspicion for malignancy. In one series of 4768 patients with nasopharyngeal carcinoma, an asymptomatic posterior triangle neck mass was the most common presenting symptom, occurring in 76 percent of patients [<a href="#rid34">34</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Supraclavicular masses, especially on the left side – Suggest malignancy metastasizing from below the clavicle, such as lung, gynecological, or gastrointestinal sources [<a href="#rid35">35</a>].</p><p></p><p class="headingAnchor" id="H10"><span class="h2">Characteristics of the mass</span><span class="headingEndMark"> — </span>Palpation of the neck mass is critical, with attention to its location, size, shape, consistency, tenderness, mobility, and color.</p><p class="bulletIndent1"><span class="glyph">●</span>Neck masses due to "reactive" lymph nodes are usually discrete, mobile, firm or rubbery but not rock hard, and slightly tender.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Rock-hard, fixed masses raise concern for malignancy. Lymph nodes representing metastatic disease may be matted to the underlying structures and are usually nontender. (See <a class="local">'Identification'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Infected lymph nodes are usually isolated, asymmetric, tender, warm, and erythematous; they may be fluctuant. (See <a class="local">'Exclude or treat bacterial infection'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Soft, ballotable, mobile masses are often congenital cysts. However, in adults, cystic neck masses may represent nodal metastases from human papillomavirus (HPV)-associated oropharyngeal squamous cell carcinoma (OPSCC) [<a href="#rid36">36</a>]. Age is an important factor in determining the differential diagnosis of a cystic neck mass. In a review of 29 isolated cystic neck lesions thought to be branchial cleft cysts, in patients over 40 years, 31 percent were found to be malignant on final pathological review [<a href="#rid37">37</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A rapidly expanding mass (over days to weeks) raises concern for infection or a rapidly growing lymphoma.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A firm, lateral neck mass that moves from side to side but not up and down indicates involvement with the carotid sheath, such as a carotid body tumor or vagal schwannoma [<a href="#rid38">38</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A pulsatile quality or bruit suggests a vascular lesion.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>An immobile midline neck mass that elevates with swallowing indicates a thyroid source, such as a thyroglossal duct cyst or thyroid tumor. (See  <a class="medical medical_review" href="/d/html/6857.html" rel="external">"Differential diagnosis of a neck mass", section on 'Thyroglossal duct cyst'</a> and  <a class="medical medical_review" href="/d/html/6857.html" rel="external">"Differential diagnosis of a neck mass", section on 'Thyroid masses'</a>.)</p><p></p><p class="headingAnchor" id="H21445615"><span class="h2">Components of the general examination</span><span class="headingEndMark"> — </span>The oral cavity and oropharynx should be examined with thorough inspection of visible mucosa and bimanual palpation of the floor of the mouth and palpable portions of the tongue and neck. Examination of the ears may indicate a unilateral serous effusion related to nasopharyngeal carcinoma. A nasopharyngeal examination should be performed if there is no obvious etiology on oral and oropharyngeal examination; this usually requires a mirror examination and/or use of a flexible fiberoptic endoscope.</p><p class="bulletIndent1"><span class="glyph">●</span>A thorough examination of the skin of the head and neck can indicate a potential primary skin malignancy such as squamous cell carcinoma or melanoma.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Assessment of cranial nerve function can suggest a neural tumor or ominous neural involvement by adjacent lymph nodes.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A generalized skin rash may suggest a viral illness, whereas a localized skin lesion may indicate a more specific etiology (eg, cat scratch disease or tularemia).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The thyroid gland should be carefully palpated and movement of the neck mass with swallowing noted. The position of the trachea should be evaluated for any deviation from midline.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The abdominal examination should pay particular attention to possible enlargement of spleen or liver and presence of any masses.</p><p></p><p class="headingAnchor" id="H12"><span class="h1">LABORATORY STUDIES</span><span class="headingEndMark"> — </span>Laboratory evaluation should be initiated when the patient history or physical examination does not suggest transient reactive lymphadenopathy as the cause of a neck mass and can be performed simultaneously with a workup for malignancy in select patients. </p><p>The extent of the laboratory evaluation will be determined by the potential differential diagnosis.</p><p class="bulletIndent1"><span class="glyph">●</span>Most patients should have:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Complete blood count (CBC) with differential</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The following may be indicated for some patients:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Erythrocyte sedimentation rate (ESR) and/or C-reactive protein (CRP) to evaluate for systemic inflammation or infection</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Blood culture (for febrile patients)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Epstein-Barr virus (EBV) or <em>Cytomegalovirus</em> (CMV) serology (when adenopathy is diffuse)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>HIV serology (in patients with increased risk)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Specific serologic tests can be ordered when there is an increased index of suspicion for disease based on exposure, history, and examination:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Serology for <em>Toxoplasma gondii</em>, brucellosis, <em>Bartonella</em> (cat scratch fever), tularemia</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><a class="drug drug_general" data-topicid="10029" href="/d/drug information/10029.html" rel="external">Tuberculin skin test</a></p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Antibodies to the Ro/SSA and La/SSB antigens, if Sjögren disease is suspected as a cause of periparotid or submandibular masses</p><p></p><p>Abnormal test results may prompt additional evaluation, such as bone marrow biopsy if the CBC indicates possible hematologic malignancy.</p><p class="headingAnchor" id="H13"><span class="h1">IMAGING STUDIES</span><span class="headingEndMark"> — </span>Imaging studies offer specific details of anatomic position, mass consistency, adjoining involvement, vascularity, and potential primary source of malignancy in the region. Imaging options include ultrasound, computed tomography (CT), magnetic resonance imaging (MRI), and combined positron emission tomography (PET)/CT fusion scans. Contrast CT should be the initial study of choice for most adult patients with a neck mass [<a href="#rid39">39-41</a>].</p><p>Ultrasound evaluation of a neck lesion is more commonly used in Europe than in the United States (US). Greater experience has developed in the US for axial imaging by CT and MRI scanning. CT and MRI allow for the characterization of the mass and its relation to normal anatomic structures of the head and neck and may also help in identifying a primary source when metastatic disease is present. Angiographic imaging variants can be obtained with both study techniques (CT angiography or MR angiography), which may be helpful in evaluating masses of possible vascular origin.</p><p class="headingAnchor" id="H3483949064"><span class="h2">Ultrasound</span><span class="headingEndMark"> — </span>The least invasive of the imaging techniques is ultrasound. Advantages of ultrasound include its noninvasive nature, real-time assessment of the mass and its relation to adjoining structures [<a href="#rid42">42-44</a>], and the ability to easily guide fine-needle aspiration. Ultrasound is an excellent initial imaging modality for those at low risk of malignant disease, such as thyroid nodules without clinical evidence of extrathyroidal invasion or rapid growth. Ultrasound is also useful in those who wish to avoid the ionizing radiation of CT, such as in younger patients or those who require frequent surveillance imaging [<a href="#rid45">45</a>]. Additionally, it is a relatively inexpensive imaging modality, with the current cost of a diagnostic neck ultrasound approximately $120 [<a href="#rid46">46</a>].</p><p>There are several disadvantages to ultrasound, however, including dependence on operator expertise and limited permanent images for use in consultant evaluation or the operative setting. Interobserver reliability in neck ultrasound is variably reported in the literature and focuses largely on the interpretation of thyroid nodules. In an evaluation of 365 patients with clinically suspected thyroid lesions all separately scanned by six ultrasonographers, interobserver reliability was excellent and increased with experience of the observer [<a href="#rid47">47</a>]. Not all studies, however, have shown such a high degree of interobserver agreement, particularly in nodule margin and echogenicity [<a href="#rid48">48</a>]. Caution should be used when making conclusions about changes in the size or character of a mass over time, especially with interfacility ultrasound comparison, as different ultrasound systems may produce significant differences in image quality and interpretation [<a href="#rid49">49</a>]. (See  <a class="medical medical_review" href="/d/html/7859.html" rel="external">"Overview of the clinical utility of ultrasonography in thyroid disease"</a>.)</p><p class="headingAnchor" id="H3698253538"><span class="h2">Computed tomography</span><span class="headingEndMark"> — </span>CT is well tolerated by patients, and reformatting algorithms allow evaluations in all relevant planes. It also yields excellent bone detail and is the study of choice for neck masses arising from or adjacent to bony structures. Image acquisition is fast, and the cost of CT is not substantially higher than that of ultrasound, with the price of contrast-enhanced neck CT approximately $240 [<a href="#rid46">46</a>]. It is an excellent initial diagnostic study in patients at higher risk of malignancy or those with possible involvement of deep neck spaces, particularly those poorly visualized by ultrasound, including parapharyngeal and masseteric spaces.</p><p>A limitation of the CT scan is its use of ionizing radiation. A typical head and neck CT imparts a radiation dose of approximately 4 mSv [<a href="#rid50">50</a>]. However, annual background radiation from natural sources in the US is approximately 3 mSv, with substantial regional variation [<a href="#rid51">51</a>]. In that way, a single CT scan has a negligible effect on a patient's lifetime incidence of developing malignancy. Consideration of the ionizing effects of CT scanning should only affect management decisions in pediatric patients, who may be at an increased risk of radiation-induced malignancy [<a href="#rid52">52</a>], and in patients undergoing very frequent surveillance imaging.</p><p class="headingAnchor" id="H816300008"><span class="h2">Magnetic resonance imaging</span><span class="headingEndMark"> — </span>MRI is indicated for masses that require further definition of soft tissue (eg, infiltrative soft tissue masses, suspicion of malignant perineural spread, or potential central nervous system origin). Advantages of MRI include outstanding soft tissue differentiation, lack of ionizing radiation, and infrequent contrast allergy [<a href="#rid39">39,53</a>]. Imaging acquisition for MRI takes longer than CT and may be challenging for claustrophobic patients. MRI is also more expensive than both ultrasound and CT, with the price of a contrast-enhanced orbits/face/neck MRI approximately $420 [<a href="#rid46">46</a>]. </p><p class="headingAnchor" id="H550660363"><span class="h2">Positron emission tomography</span><span class="headingEndMark"> — </span>PET/CT fusion scans have been found useful in the setting of malignancy, aiding in the identification of primary disease, or detection of distant metastatic disease [<a href="#rid54">54</a>]. PET/CT is primarily helpful in the later evaluation of malignancies and plays little role in the initial evaluation of the neck mass. PET/CT scanning does impart a significantly high equivalent radiation dose, which may be as high as 32 mSv and, with frequent scanning, may appreciably increase the lifetime attributable risk of malignancy [<a href="#rid55">55</a>]. (See  <a class="medical medical_review" href="/d/html/3393.html" rel="external">"Overview of the diagnosis and staging of head and neck cancer", section on 'PET and integrated PET/CT'</a>.)</p><p class="headingAnchor" id="H37621057"><span class="h1">DIAGNOSTIC STUDIES</span></p><p class="headingAnchor" id="H14"><span class="h2">Fine-needle aspiration</span><span class="headingEndMark"> — </span>Fine-needle aspiration (FNA) is the preferred diagnostic approach for most neck masses and is typically performed using a 25 or 27 gauge needle on a 20 mL syringe [<a href="#rid56">56,57</a>]. The nature of the aspirate may suggest particular etiologies:</p><p class="bulletIndent1"><span class="glyph">●</span>Blood (vascular lesion)</p><p class="bulletIndent1"><span class="glyph">●</span>Serous dark brown fluid (papillary thyroid cancer)</p><p class="bulletIndent1"><span class="glyph">●</span>Thick viscous yellow fluid (mucocele)</p><p class="bulletIndent1"><span class="glyph">●</span>Turbid yellow fluid (branchial cleft cyst)</p><p class="bulletIndent1"><span class="glyph">●</span>Purulent (abscess)</p><p></p><p>Whether performed in the office or a radiology suite, on-site evaluation of FNA samples by trained cytopathologists results in the lowest rate of sample inadequacy (6 versus &gt;10 percent) [<a href="#rid58">58</a>]. The initial cytopathological analysis of FNA is by smear preparation, which may be limited by blood products, hypocellularity, and variable smear thickness. The addition of cell block preparation to standard cytopathological analysis has been shown to reduce the rate of unsatisfactory samples and improve diagnostic accuracy [<a href="#rid59">59</a>]. </p><p>Cell blocks are prepared by centrifugation of material obtained through FNA, which can then be sectioned for further pathological analysis, including immunohistochemical staining. This can be especially useful in certain pathologies, including lymphoma [<a href="#rid60">60</a>] and human papillomavirus (HPV)-associated oropharyngeal squamous cell carcinoma (OPSCC) [<a href="#rid61">61</a>]. In particular, FNA is an important initial diagnostic tool in patients at risk for lymphoma. Even if initial needle biopsy is unable to provide exact subtype definition, FNA can quickly rule out carcinoma or other pathology in these patients and identify those who would benefit from excisional biopsy. Cell block preparations may also be archived for future analysis or use in research protocols.</p><p>Besides cytologic analysis, FNA aspirate can also be submitted for polymerase chain reaction (PCR) testing for virus such as the presence of Epstein-Barr virus (EBV), which can suggest the diagnosis of a nasopharyngeal carcinoma, or HPV, which has been implicated in OPSCC. </p><p>FNA is a safe, highly accurate diagnostic procedure [<a href="#rid57">57,62,63</a>] but is dependent upon the skills of the clinician performing the procedure to avoid sampling errors and the accuracy of cytopathological interpretation. A meta-analysis found an overall accuracy of 93 percent (ranged 73 to 98 percent) for FNA in diagnosing all neck masses regardless of location or histology [<a href="#rid64">64</a>]. </p><p>The isolated lateral neck cyst in an adult, however, remains a diagnostic challenge. As discussed above, in patients over 40 years, lateral neck cysts may represent cervical metastasis from HPV-associated OPSCC. In these masses, the cyst lining is often the only diagnostic component, which decreases the specificity of FNA, especially that performed without image guidance [<a href="#rid65">65</a>]. In a review of 121 lateral neck cysts, metastatic squamous cell carcinoma was identified in 24 percent of patients over 40 years [<a href="#rid32">32</a>]. However, of patients who underwent preoperative FNA, over 30 percent with negative FNA results were subsequently found to have malignant pathology after cyst excision. For this reason, the treating clinician must maintain a high degree of suspicion in older adult patients with isolated neck cysts despite a negative FNA. Analysis of cyst fluid for HPV DNA and the use of cell block analysis may improve diagnostic accuracy in cases of occult HPV-associated OPSCC [<a href="#rid66">66</a>]. (See <a class="local">'Excisional or incisional biopsy'</a> below.)</p><p class="headingAnchor" id="H37621065"><span class="h2">Core biopsy</span><span class="headingEndMark"> — </span>If the information provided by an FNA does not establish the diagnosis, core needle biopsy can be considered. Core biopsies in the head and neck are generally performed under local anesthesia with a 14 to 20 gauge cutting needle. One to five passes are typically performed with an automatic needle gun for precise tissue acquisition [<a href="#rid67">67</a>]. </p><p>Advantages of core biopsy include greater tissue yield, leading to lower rates of nondiagnostic samples; decreased variability in pathological interpretation; and improved diagnostic accuracy in specific disease processes that require analysis of tissue architecture or flow cytometry, such as lymphoma [<a href="#rid68">68</a>]. In a review of 237 patients who underwent core needle biopsy in the workup of lymphoma, 97 percent were fully diagnostic, allowing treatment initiation without excisional node biopsy [<a href="#rid69">69</a>]. </p><p>The disadvantages of core biopsy are primarily related to the potential trauma from larger-bore needles. Although increasing needle size may theoretically increase the risk of nerve injury or tumor seeding, in practice these events are exceedingly rare and do not appear more frequently for core biopsy than FNA. In a systematic review of the literature including 610 articles, the estimated rates of tumor seeding after either FNA or core biopsy were below 0.002 percent [<a href="#rid70">70</a>]. </p><p class="headingAnchor" id="H2689403443"><span class="h2">Image-guided biopsy</span><span class="headingEndMark"> — </span>Ultrasound-guided or CT-guided FNA or core biopsies are considered in the setting of nonpalpable masses seen only with imaging. Advantages of image guidance include precise sampling adjacent to critical neurovascular structures as well as the ability to target higher-yield areas within a complex cystic-solid lesion. A randomized trial involving 81 patients with a head and neck mass less than 3 cm demonstrated improved tissue adequacy for FNA using ultrasound guidance as compared with palpation alone [<a href="#rid71">71</a>]. Most neck masses within 3 cm of the skin surface are amenable to ultrasound guidance. CT procedures are used for deeper lesions or those without an echogenic window, such as high neck masses under the mandible [<a href="#rid72">72</a>]. </p><p class="headingAnchor" id="H37621073"><span class="h2">Excisional or incisional biopsy</span><span class="headingEndMark"> — </span>Open surgical biopsies, in general, are discouraged since they can adversely affect the success of subsequent definitive treatment in malignant pathologies and in certain situations, even for benign disease, may lead to disastrous results: </p><p class="bulletIndent1"><span class="glyph">●</span>Open biopsy of paragangliomas of the head and neck could result in life-threatening hemorrhagic complications. (See  <a class="medical medical_review" href="/d/html/86542.html" rel="external">"Paragangliomas: Treatment of locoregional disease", section on 'Preoperative evaluation'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Open biopsy of schwannomas, including those arising from the vagal or facial nerves, may result in permanent and unexpected nerve deficits. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Periparotid masses may represent salivary gland neoplasms, and open biopsy may increase the risk of tumor recurrence and increase the technical difficulty of subsequent definitive resection.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>For excisional node biopsies that are found to be metastatic squamous cell carcinoma, the ultimate impact of open biopsy on oncologic control remains controversial. However, surgical excisional or incisional biopsy of a neck lesion that is subsequently found to be malignant creates several challenges for both the patient and treating clinicians. If definitive surgery is later performed, completion lymph node dissection is substantially more difficult in the setting of prior surgery. In addition, open biopsy risks tumor spillage and requires resection of prior incisions and surrounding scar or may require higher radiotherapy dosing to the prior surgical bed when definitive nonsurgical treatment is delivered [<a href="#rid73">73</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Open biopsy is acceptable in the setting of an FNA or core biopsy being positive for lymphoma when additional tissue is necessary for subtyping.</p><p></p><p>If open resection of a cystic neck mass with benign or nondiagnostic FNA results is considered, referral must be made to a provider capable of performing completion node dissection in the same setting should the diagnosis return intraoperatively as a malignant head and neck cancer [<a href="#rid65">65</a>]. This is particularly relevant in the HPV-associated OPSCC era where young nonsmokers with few comorbidities may present with cystic neck lesions initially mistaken for congenital cysts. As discussed above, needle biopsy of these masses is often nondiagnostic or falsely negative given their cystic nature, and a high level of suspicion must be maintained in these patients [<a href="#rid25">25</a>]. (See <a class="local">'Other history'</a> above and  <a class="medical medical_review" href="/d/html/3378.html" rel="external">"Epidemiology, staging, and clinical presentation of human papillomavirus associated head and neck cancer", section on 'Treatment'</a>.)</p><p class="headingAnchor" id="H2629660926"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/128542.html" rel="external">"Society guideline links: Neck mass"</a>.)</p><p class="headingAnchor" id="H15"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Differential diagnosis of a neck mass</strong> – Evaluation of a neck mass must be approached in a thorough and disciplined manner as the neck mass may be the only manifestation of a potentially malignant pathology, especially in the adult population. Our approach for this evaluation is as follows (see <a class="local">'Introduction'</a> above and <a class="local">'Our approach'</a> above):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Infectious neck masses must be promptly treated with a course of broad-spectrum antibiotics (eg, <a class="drug drug_general" data-topicid="8676" href="/d/drug information/8676.html" rel="external">amoxicillin-clavulanate</a>) and followed to resolution. (See <a class="local">'Exclude or treat bacterial infection'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Most neck masses in adults are neoplastic or malignant. Neck masses that are noninfectious; have been present for ≥2 weeks or an unknown duration; and are fixed, firm, &gt;1.5 cm in size, and with ulceration of overlying skin are at increased risk of being malignant. Additional findings on the history and physical examination may also suggest a malignant etiology. Patients suspected to have a malignant neck mass should be referred to a specialist and undergo contrast computed tomography (CT) of the neck and biopsy of the mass. (See <a class="local">'Exclude malignancy'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Ancillary laboratory and imaging tests can be used to diagnose neck masses at any time in any patients but should be directed by clinical indications. (See <a class="local">'Establish diagnosis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Patient history</strong> – The evaluation of a new neck mass begins with a thorough history and physical examination. Key components of the history include age; demographics; rate of change of the mass; symptoms of pain; symptoms of systemic illness; and use of tobacco, alcohol, or illicit drugs. (See <a class="local">'Patient history'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Physical examination</strong> – The physical examination should identify the localization of the mass and its texture and mobility and should include careful evaluation of the oral cavity, cranial nerves, thyroid gland, and a comprehensive general examination. (See <a class="local">'Physical examination'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Laboratory studies</strong> – Laboratory studies should be ordered based on findings from the history and physical examination. (See <a class="local">'Laboratory studies'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Imaging studies</strong> – Imaging studies usually start with a contrast CT scan of the neck, though an ultrasound evaluation is also acceptable if there is technical expertise; magnetic resonance imaging (MRI) or positron emission tomography (PET)/CT scanning may be indicated in follow-up. (See <a class="local">'Imaging studies'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Biopsies</strong> – Fine-needle aspiration (FNA) can provide initial tissue sampling but is not always definitive. Core biopsy may increase diagnostic yield, and current evidence suggests that the risks of core biopsy are similar to those of FNA. Image guidance can aid in the needle biopsy of nonpalpable lesions. If needle biopsies continue to reveal nondiagnostic samples, open biopsy may be considered, but referral must be made to a surgeon trained in the management of malignant head and neck tumors who is capable of performing completion lymph node dissection in the same setting should this become necessary. (See <a class="local">'Diagnostic studies'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>HPV-associated oropharyngeal squamous cell carcinoma</strong> – Clinicians need to be aware of the rising incidence of human papillomavirus (HPV)-associated oropharyngeal squamous cell carcinoma (OPSCC). HPV-associated OPSCC often presents as an asymptomatic cystic neck mass in young patients without traditional risk factors (eg, smoking or drinking) and can easily be mistaken for a congenital cyst. Needle biopsies are often nondiagnostic or falsely negative because the cyst lining is the only diagnostic component. A high level of suspicion must be maintained in these patients, and surgeons performing any open resection must be prepared for a possible completion node dissection in the same setting. (See <a class="local">'Other history'</a> above and <a class="local">'Fine-needle aspiration'</a> above and <a class="local">'Excisional or incisional biopsy'</a> above and  <a class="medical medical_review" href="/d/html/3378.html" rel="external">"Epidemiology, staging, and clinical presentation of human papillomavirus associated head and neck cancer", section on 'Oropharyngeal carcinoma'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Neck mass related to COVID-19 vaccination</strong> – The immunogenicity of the COVID-19 vaccine can lead to reactive cervical, axillary, or subpectoral adenopathy ipsilateral to the injection site. Thus, elective screening studies for head and neck cancer patients should be scheduled either before or at least six weeks after the COVID-19 vaccine. If imaging must be obtained sooner, the vaccine should be administered contralateral to the patient's cancer when possible. (See <a class="local">'COVID-19 vaccination'</a> above.)</p><p></p><p class="headingAnchor" id="H3318825140"><span class="h1">ACKNOWLEDGMENT</span><span class="headingEndMark"> — </span>The UpToDate editorial staff acknowledges Derrick Lin, MD, who contributed to an earlier version of this topic review.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Alvi A, Johnson JT. The neck mass. A challenging differential diagnosis. Postgrad Med 1995; 97:87.</a></li><li><a class="nounderline abstract_t">Weymuller EA Jr. Evaluation of neck masses. J Fam Pract 1980; 11:1099.</a></li><li><a class="nounderline abstract_t">Pynnonen MA, Gillespie MB, Roman B, et al. Clinical Practice Guideline: Evaluation of the Neck Mass in Adults. Otolaryngol Head Neck Surg 2017; 157:S1.</a></li><li><a class="nounderline abstract_t">Schwetschenau E, Kelley DJ. The adult neck mass. Am Fam Physician 2002; 66:831.</a></li><li><a class="nounderline abstract_t">Kshirsagar RS, Anderson M, Boeckermann LM, et al. The Adult Neck Mass: Predictors of Malignancy. Otolaryngol Head Neck Surg 2021; 165:673.</a></li><li><a class="nounderline abstract_t">Enepekides DJ. Management of congenital anomalies of the neck. Facial Plast Surg Clin North Am 2001; 9:131.</a></li><li><a class="nounderline abstract_t">Otto RA, Bowes AK. Neck masses: benign or malignant? Sorting out the causes by age-group. Postgrad Med 1990; 88:199.</a></li><li><a class="nounderline abstract_t">Turkington JR, Paterson A, Sweeney LE, Thornbury GD. Neck masses in children. Br J Radiol 2005; 78:75.</a></li><li><a class="nounderline abstract_t">Brown RL, Azizkhan RG. Pediatric head and neck lesions. Pediatr Clin North Am 1998; 45:889.</a></li><li><a class="nounderline abstract_t">Mendenhall WM, Mancuso AA, Amdur RJ, et al. Squamous cell carcinoma metastatic to the neck from an unknown head and neck primary site. Am J Otolaryngol 2001; 22:261.</a></li><li><a class="nounderline abstract_t">Ruhl C. Evaluation of the neck mass. Med Health R I 2004; 87:307.</a></li><li><a class="nounderline abstract_t">Davis RJ, Rettig E, Aygun N, et al. From presumed benign neck masses to delayed recognition of human papillomavirus-positive oropharyngeal cancer. Laryngoscope 2020; 130:392.</a></li><li><a class="nounderline abstract_t">Rosenberg TL, Phillips JD. Update on Vascular Anomalies of the Head and Neck. Otolaryngol Clin North Am 2022; 55:1215.</a></li><li><a class="nounderline abstract_t">Weber AL, Rahemtullah A, Ferry JA. Hodgkin and non-Hodgkin lymphoma of the head and neck: clinical, pathologic, and imaging evaluation. Neuroimaging Clin N Am 2003; 13:371.</a></li><li><a class="nounderline abstract_t">Mourad M, Jetmore T, Jategaonkar AA, et al. Epidemiological Trends of Head and Neck Cancer in the United States: A SEER Population Study. J Oral Maxillofac Surg 2017; 75:2562.</a></li><li><a class="nounderline abstract_t">Weatherspoon DJ, Chattopadhyay A, Boroumand S, Garcia I. Oral cavity and oropharyngeal cancer incidence trends and disparities in the United States: 2000-2010. Cancer Epidemiol 2015; 39:497.</a></li><li><a class="nounderline abstract_t">Amini A, Jasem J, Jones BL, et al. Predictors of overall survival in human papillomavirus-associated oropharyngeal cancer using the National Cancer Data Base. Oral Oncol 2016; 56:1.</a></li><li><a class="nounderline abstract_t">Liederbach E, Kyrillos A, Wang CH, et al. The national landscape of human papillomavirus-associated oropharynx squamous cell carcinoma. Int J Cancer 2017; 140:504.</a></li><li><a class="nounderline abstract_t">Roman BR, Aragones A. Epidemiology and incidence of HPV-related cancers of the head and neck. J Surg Oncol 2021; 124:920.</a></li><li><a class="nounderline abstract_t">Centers for Disease Control and Prevention (CDC). Human papillomavirus-associated cancers - United States, 2004-2008. MMWR Morb Mortal Wkly Rep 2012; 61:258.</a></li><li><a class="nounderline abstract_t">Viens LJ, Henley SJ, Watson M, et al. Human Papillomavirus-Associated Cancers - United States, 2008-2012. MMWR Morb Mortal Wkly Rep 2016; 65:661.</a></li><li><a class="nounderline abstract_t">Saraiya M, Unger ER, Thompson TD, et al. US assessment of HPV types in cancers: implications for current and 9-valent HPV vaccines. J Natl Cancer Inst 2015; 107:djv086.</a></li><li><a class="nounderline abstract_t">Lechner M, Liu J, Masterson L, Fenton TR. HPV-associated oropharyngeal cancer: epidemiology, molecular biology and clinical management. Nat Rev Clin Oncol 2022; 19:306.</a></li><li><a class="nounderline abstract_t">McIlwain WR, Sood AJ, Nguyen SA, Day TA. Initial symptoms in patients with HPV-positive and HPV-negative oropharyngeal cancer. JAMA Otolaryngol Head Neck Surg 2014; 140:441.</a></li><li><a class="nounderline abstract_t">Truong Lam M, O'Sullivan B, Gullane P, Huang SH. Challenges in establishing the diagnosis of human papillomavirus-related oropharyngeal carcinoma. Laryngoscope 2016; 126:2270.</a></li><li><a class="nounderline abstract_t">Valero C, Shah JP. Staging of human papilloma virus related cancers of the oropharynx. J Surg Oncol 2021; 124:931.</a></li><li><a class="nounderline abstract_t">Schroeder DG, Jang S, Johnson DR, et al. Frequency and Characteristics of Nodal and Deltoid FDG and 11C-Choline Uptake on PET Performed After COVID-19 Vaccination. AJR Am J Roentgenol 2021; 217:1206.</a></li><li><a class="nounderline abstract_t">Mitchell OR, Couzins M, Dave R, et al. COVID-19 vaccination and low cervical lymphadenopathy in the two week neck lump clinic - a follow up audit. Br J Oral Maxillofac Surg 2021; 59:720.</a></li><li><a class="nounderline abstract_t">Shah S, Wagner T, Nathan M, Szyszko T. COVID-19 vaccine-related lymph node activation - patterns of uptake on PET-CT. BJR Case Rep 2021; 7:20210040.</a></li><li><a class="nounderline abstract_t">Cardoso F, Reis A, Osório C, et al. A Case of Cervical Lymphadenopathy After Vaccination Against COVID-19. Cureus 2021; 13:e15050.</a></li><li><a class="nounderline abstract_t">Becker AS, Perez-Johnston R, Chikarmane SA, et al. Multidisciplinary Recommendations Regarding Post-Vaccine Adenopathy and Radiologic Imaging: Radiology Scientific Expert Panel. Radiology 2021; 300:E323.</a></li><li><a class="nounderline abstract_t">Gourin CG, Johnson JT. Incidence of unsuspected metastases in lateral cervical cysts. Laryngoscope 2000; 110:1637.</a></li><li><a class="nounderline abstract_t">Kupferman ME, Patterson M, Mandel SJ, et al. Patterns of lateral neck metastasis in papillary thyroid carcinoma. Arch Otolaryngol Head Neck Surg 2004; 130:857.</a></li><li><a class="nounderline abstract_t">Wei WI, Sham JS. Nasopharyngeal carcinoma. Lancet 2005; 365:2041.</a></li><li><a class="nounderline abstract_t">Giridharan W, Hughes J, Fenton JE, Jones AS. Lymph node metastases in the lower neck. Clin Otolaryngol Allied Sci 2003; 28:221.</a></li><li><a class="nounderline abstract_t">Goldenberg D, Begum S, Westra WH, et al. Cystic lymph node metastasis in patients with head and neck cancer: An HPV-associated phenomenon. Head Neck 2008; 30:898.</a></li><li><a class="nounderline abstract_t">Sira J, Makura ZG. Differential diagnosis of cystic neck lesions. Ann Otol Rhinol Laryngol 2011; 120:409.</a></li><li><a class="nounderline abstract_t">Pellitteri PK, Rinaldo A, Myssiorek D, et al. Paragangliomas of the head and neck. Oral Oncol 2004; 40:563.</a></li><li><a class="nounderline abstract_t">Weber AL, Romo L, Hashmi S. Malignant tumors of the oral cavity and oropharynx: clinical, pathologic, and radiologic evaluation. Neuroimaging Clin N Am 2003; 13:443.</a></li><li><a class="nounderline abstract_t">Wetmore RF, Mahboubi S, Soyupak SK. Computed tomography in the evaluation of pediatric neck infections. Otolaryngol Head Neck Surg 1998; 119:624.</a></li><li><a class="nounderline abstract_t">Sakai O, Curtin HD, Romo LV, Som PM. Lymph node pathology. Benign proliferative, lymphoma, and metastatic disease. Radiol Clin North Am 2000; 38:979.</a></li><li><a class="nounderline abstract_t">Chang DB, Yang PC, Luh KT, et al. Ultrasonic evaluation of cervical lymphadenopathy. J Formos Med Assoc 1990; 89:286.</a></li><li><a class="nounderline abstract_t">Douglas SA, Jennings S, Owen VM, et al. Is ultrasound useful for evaluating paediatric inflammatory neck masses? Clin Otolaryngol 2005; 30:526.</a></li><li><a class="nounderline abstract_t">Gritzmann N, Hollerweger A, Macheiner P, Rettenbacher T. Sonography of soft tissue masses of the neck. J Clin Ultrasound 2002; 30:356.</a></li><li><a class="nounderline abstract_t">Feier J, Self Q, Karabachev A, et al. Assessing the role of ultrasound for the evaluation of adult neck masses. Laryngoscope Investig Otolaryngol 2023; 8:135.</a></li><li class="breakAll">Centers for Medicare &amp; Medicaid Services (CMS). Overview of the Medicare Physician Fee Schedule (MPFS). Available at: https://www.cms.gov/apps/physician-fee-schedule/overview.aspx (Accessed on October 20, 2017).</li><li><a class="nounderline abstract_t">Srinivas MN, Amogh VN, Gautam MS, et al. A Prospective Study to Evaluate the Reliability of Thyroid Imaging Reporting and Data System in Differentiation between Benign and Malignant Thyroid Lesions. J Clin Imaging Sci 2016; 6:5.</a></li><li><a class="nounderline abstract_t">Moon WJ, Jung SL, Lee JH, et al. Benign and malignant thyroid nodules: US differentiation--multicenter retrospective study. Radiology 2008; 247:762.</a></li><li><a class="nounderline abstract_t">Lorentsson R, Hosseini N, Johansson JO, et al. Comparison of the low-contrast detectability of two ultrasound systems using a grayscale phantom. J Appl Clin Med Phys 2016; 17:366.</a></li><li><a class="nounderline abstract_t">Sodickson A, Baeyens PF, Andriole KP, et al. Recurrent CT, cumulative radiation exposure, and associated radiation-induced cancer risks from CT of adults. Radiology 2009; 251:175.</a></li><li><a class="nounderline abstract_t">Moeller DW, Sun LS. Comparison of natural background dose rates for residents of the Amargosa Valley, NV, to those in Leadville, CO, and the states of Colorado and Nevada. Health Phys 2006; 91:338.</a></li><li><a class="nounderline abstract_t">Pearce MS, Salotti JA, Little MP, et al. Radiation exposure from CT scans in childhood and subsequent risk of leukaemia and brain tumours: a retrospective cohort study. Lancet 2012; 380:499.</a></li><li><a class="nounderline abstract_t">Ishikawa M, Anzai Y. MR imaging of lymph nodes in the head and neck. Neuroimaging Clin N Am 2004; 14:679.</a></li><li><a class="nounderline abstract_t">McGuirt WF, Greven K, Williams D 3rd, et al. PET scanning in head and neck oncology: a review. Head Neck 1998; 20:208.</a></li><li><a class="nounderline abstract_t">Huang B, Law MW, Khong PL. Whole-body PET/CT scanning: estimation of radiation dose and cancer risk. Radiology 2009; 251:166.</a></li><li><a class="nounderline abstract_t">Amedee RG, Dhurandhar NR. Fine-needle aspiration biopsy. Laryngoscope 2001; 111:1551.</a></li><li><a class="nounderline abstract_t">Tatomirovic Z, Skuletic V, Bokun R, et al. Fine needle aspiration cytology in the diagnosis of head and neck masses: accuracy and diagnostic problems. J BUON 2009; 14:653.</a></li><li><a class="nounderline abstract_t">Ganguly A, Burnside G, Nixon P. A systematic review of ultrasound-guided FNA of lesions in the head and neck--focusing on operator, sample inadequacy and presence of on-spot cytology service. Br J Radiol 2014; 87:20130571.</a></li><li><a class="nounderline abstract_t">Cristo AP, Goldstein HF, Faccin CS, et al. Increasing diagnostic effectiveness of thyroid nodule evaluation by implementation of cell block preparation in routine US-FNA analysis. Arch Endocrinol Metab 2016; 60:367.</a></li><li><a class="nounderline abstract_t">Zhang S, Yu X, Zheng Y, et al. Value of fine needle aspiration cell blocks in the diagnosis and classification of lymphoma. Int J Clin Exp Pathol 2014; 7:7717.</a></li><li><a class="nounderline abstract_t">Hou Y, Chaudhary S, Shen R, Li Z. Fine-needle aspiration of cervical lymph nodes yields adequate materials for accurate HPV testing in metastatic head and neck squamous cell carcinomas. Diagn Cytopathol 2016; 44:792.</a></li><li><a class="nounderline abstract_t">Layfield LJ. Fine-needle aspiration in the diagnosis of head and neck lesions: a review and discussion of problems in differential diagnosis. Diagn Cytopathol 2007; 35:798.</a></li><li><a class="nounderline abstract_t">Carroll CM, Nazeer U, Timon CI. The accuracy of fine-needle aspiration biopsy in the diagnosis of head and neck masses. Ir J Med Sci 1998; 167:149.</a></li><li><a class="nounderline abstract_t">Tandon S, Shahab R, Benton JI, et al. Fine-needle aspiration cytology in a regional head and neck cancer center: comparison with a systematic review and meta-analysis. Head Neck 2008; 30:1246.</a></li><li><a class="nounderline abstract_t">Saliba M, Ghossein R, Xu B. HPV-related head and neck cancers: Pathology and biology. J Surg Oncol 2021; 124:923.</a></li><li><a class="nounderline abstract_t">Yasui T, Morii E, Yamamoto Y, et al. Human papillomavirus and cystic node metastasis in oropharyngeal cancer and cancer of unknown primary origin. PLoS One 2014; 9:e95364.</a></li><li><a class="nounderline abstract_t">Novoa E, Gürtler N, Arnoux A, Kraft M. Role of ultrasound-guided core-needle biopsy in the assessment of head and neck lesions: a meta-analysis and systematic review of the literature. Head Neck 2012; 34:1497.</a></li><li><a class="nounderline abstract_t">Douville NJ, Bradford CR. Comparison of ultrasound-guided core biopsy versus fine-needle aspiration biopsy in the evaluation of salivary gland lesions. Head Neck 2013; 35:1657.</a></li><li><a class="nounderline abstract_t">Skelton E, Jewison A, Okpaluba C, et al. Image-guided core needle biopsy in the diagnosis of malignant lymphoma. Eur J Surg Oncol 2015; 41:852.</a></li><li><a class="nounderline abstract_t">Shah KS, Ethunandan M. Tumour seeding after fine-needle aspiration and core biopsy of the head and neck--a systematic review. Br J Oral Maxillofac Surg 2016; 54:260.</a></li><li><a class="nounderline abstract_t">Robitschek J, Straub M, Wirtz E, et al. Diagnostic efficacy of surgeon-performed ultrasound-guided fine needle aspiration: a randomized controlled trial. Otolaryngol Head Neck Surg 2010; 142:306.</a></li><li><a class="nounderline abstract_t">Lorenzo G, Saindane AM. Pitfalls in image guided tissue sampling in the head and neck. Neuroimaging Clin N Am 2013; 23:167.</a></li><li><a class="nounderline abstract_t">Zenga J, Graboyes EM, Haughey BH, et al. Definitive Surgical Therapy after Open Neck Biopsy for HPV-Related Oropharyngeal Cancer. Otolaryngol Head Neck Surg 2016; 154:657.</a></li></ol></div><div id="topicVersionRevision">Topic 6848 Version 22.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7753749" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : The neck mass. A challenging differential diagnosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7452169" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Evaluation of neck masses.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28891406" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Clinical Practice Guideline: Evaluation of the Neck Mass in Adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12322776" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : The adult neck mass.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33687292" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : The Adult Neck Mass: Predictors of Malignancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11465000" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Management of congenital anomalies of the neck.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2367255" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Neck masses: benign or malignant? Sorting out the causes by age-group.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15673538" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Neck masses in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9728193" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Pediatric head and neck lesions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11464323" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Squamous cell carcinoma metastatic to the neck from an unknown head and neck primary site.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15559383" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Evaluation of the neck mass.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30950517" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : From presumed benign neck masses to delayed recognition of human papillomavirus-positive oropharyngeal cancer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36371136" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Update on Vascular Anomalies of the Head and Neck.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14631680" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Hodgkin and non-Hodgkin lymphoma of the head and neck: clinical, pathologic, and imaging evaluation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28618252" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Epidemiological Trends of Head and Neck Cancer in the United States: A SEER Population Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25976107" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Oral cavity and oropharyngeal cancer incidence trends and disparities in the United States: 2000-2010.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27086480" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Predictors of overall survival in human papillomavirus-associated oropharyngeal cancer using the National Cancer Data Base.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27667729" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : The national landscape of human papillomavirus-associated oropharynx squamous cell carcinoma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34558067" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Epidemiology and incidence of HPV-related cancers of the head and neck.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22513527" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Human papillomavirus-associated cancers - United States, 2004-2008.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27387669" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Human Papillomavirus-Associated Cancers - United States, 2008-2012.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25925419" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : US assessment of HPV types in cancers: implications for current and 9-valent HPV vaccines.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35105976" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : HPV-associated oropharyngeal cancer: epidemiology, molecular biology and clinical management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24652023" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Initial symptoms in patients with HPV-positive and HPV-negative oropharyngeal cancer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27074870" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Challenges in establishing the diagnosis of human papillomavirus-related oropharyngeal carcinoma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34622962" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Staging of human papilloma virus related cancers of the oropharynx.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34009000" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Frequency and Characteristics of Nodal and Deltoid FDG and 11C-Choline Uptake on PET Performed After COVID-19 Vaccination.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33947605" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : COVID-19 vaccination and low cervical lymphadenopathy in the two week neck lump clinic - a follow up audit.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34131510" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : COVID-19 vaccine-related lymph node activation - patterns of uptake on PET-CT.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34141500" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : A Case of Cervical Lymphadenopathy After Vaccination Against COVID-19.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33625298" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Multidisciplinary Recommendations Regarding Post-Vaccine Adenopathy and Radiologic Imaging: Radiology Scientific Expert Panel.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11037817" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Incidence of unsuspected metastases in lateral cervical cysts.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15262763" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Patterns of lateral neck metastasis in papillary thyroid carcinoma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15950718" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Nasopharyngeal carcinoma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12755760" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Lymph node metastases in the lower neck.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18383529" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Cystic lymph node metastasis in patients with head and neck cancer: An HPV-associated phenomenon.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21774450" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Differential diagnosis of cystic neck lesions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15063383" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Paragangliomas of the head and neck.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14631684" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Malignant tumors of the oral cavity and oropharynx: clinical, pathologic, and radiologic evaluation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9852537" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Computed tomography in the evaluation of pediatric neck infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11054964" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Lymph node pathology. Benign proliferative, lymphoma, and metastatic disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1976745" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Ultrasonic evaluation of cervical lymphadenopathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16402978" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Is ultrasound useful for evaluating paediatric inflammatory neck masses?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12116098" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Sonography of soft tissue masses of the neck.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36846436" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Assessing the role of ultrasound for the evaluation of adult neck masses.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36846436" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Assessing the role of ultrasound for the evaluation of adult neck masses.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27014501" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : A Prospective Study to Evaluate the Reliability of Thyroid Imaging Reporting and Data System in Differentiation between Benign and Malignant Thyroid Lesions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18403624" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Benign and malignant thyroid nodules: US differentiation--multicenter retrospective study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27929509" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Comparison of the low-contrast detectability of two ultrasound systems using a grayscale phantom.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19332852" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Recurrent CT, cumulative radiation exposure, and associated radiation-induced cancer risks from CT of adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16966877" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Comparison of natural background dose rates for residents of the Amargosa Valley, NV, to those in Leadville, CO, and the states of Colorado and Nevada.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22681860" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Radiation exposure from CT scans in childhood and subsequent risk of leukaemia and brain tumours: a retrospective cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15489148" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : MR imaging of lymph nodes in the head and neck.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9570626" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : PET scanning in head and neck oncology: a review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19251940" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Whole-body PET/CT scanning: estimation of radiation dose and cancer risk.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11568593" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Fine-needle aspiration biopsy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20148458" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Fine needle aspiration cytology in the diagnosis of head and neck masses: accuracy and diagnostic problems.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25247346" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : A systematic review of ultrasound-guided FNA of lesions in the head and neck--focusing on operator, sample inadequacy and presence of on-spot cytology service.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27533613" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Increasing diagnostic effectiveness of thyroid nodule evaluation by implementation of cell block preparation in routine US-FNA analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25550808" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Value of fine needle aspiration cell blocks in the diagnosis and classification of lymphoma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27465660" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Fine-needle aspiration of cervical lymph nodes yields adequate materials for accurate HPV testing in metastatic head and neck squamous cell carcinomas.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18008348" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Fine-needle aspiration in the diagnosis of head and neck lesions: a review and discussion of problems in differential diagnosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9780562" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : The accuracy of fine-needle aspiration biopsy in the diagnosis of head and neck masses.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18528906" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Fine-needle aspiration cytology in a regional head and neck cancer center: comparison with a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34582040" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : HPV-related head and neck cancers: Pathology and biology.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24752007" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Human papillomavirus and cystic node metastasis in oropharyngeal cancer and cancer of unknown primary origin.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22127851" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Role of ultrasound-guided core-needle biopsy in the assessment of head and neck lesions: a meta-analysis and systematic review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23109044" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Comparison of ultrasound-guided core biopsy versus fine-needle aspiration biopsy in the evaluation of salivary gland lesions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25980745" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Image-guided core needle biopsy in the diagnosis of malignant lymphoma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26837638" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Tumour seeding after fine-needle aspiration and core biopsy of the head and neck--a systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20172371" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Diagnostic efficacy of surgeon-performed ultrasound-guided fine needle aspiration: a randomized controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23199667" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Pitfalls in image guided tissue sampling in the head and neck.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26861231" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Definitive Surgical Therapy after Open Neck Biopsy for HPV-Related Oropharyngeal Cancer.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
